Biocept Inc (NASDAQ:BIOC)
| 0.8985 Delayed Data As of Aug 14 |  -0.1115 / -11.04%Today’s Change | 0.21 Today|||52-Week Range 1.30 | +214.16% Year-to-Date |
Latest BIOC News | Press Releases
| Biocept to provide COVID-19 testing to multi-state locations Aug 13 / Seeking Alpha - Paid Partner Content | Biocept EPS in-line, misses on revenue Aug 12 / Seeking Alpha - Paid Partner Content |
| Biocept, Inc. (BIOC) CEO Michael Nall on Q2 2020 Results - Earnings Call Transcript Aug 12 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 1.01 |
| Today’s open | 1.02 |
| Day’s range | 0.86 - 1.02 |
| Volume | 945,217 |
| Average volume (3 months) | 27,174,590 |
| Market cap | $131.1M |
Data as of 4:14pm ET, 08/14/2020
Growth & Valuation
| Earnings growth (last year) | +86.43% |
| Earnings growth (this year) | +82.38% |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | +70.09% |
| P/E ratio | NM |
| Price/Sales | 1.07 |
| Price/Book | 4.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FORRForrester Research I... | -0.01 | -0.03% |
| NRCNational Research Co... | -1.48 | -2.60% |
Data as of 3:59pm ET, 08/14/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $5.5M |
| Annual profit (last year) | -$25.1M |
| Net profit margin | -454.69% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
